Premier Research: Clinical Trials

92 trials sponsored by Premier Research, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

64 completed, 12 terminated, 5 unknown, 4 recruiting. 43 Phase 2, 36 Phase 3, 9 Phase 1, 4 Phase 4, 3 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 243Completed 31, Terminated 5, Recruiting 3, Enrolling by invitation 1, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 336Completed 27, Terminated 4, Recruiting 2, Unknown 2, Suspended 1
Phase 19Completed 5, Terminated 2, Active not recruiting 1, Unknown 1
Phase 44Completed 2, Terminated 1, Withdrawn 1
Not applicable3Completed 2, Unknown 1

Follow Premier Research: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle
FB-301, Placebo, Chlorhexidine (0.5%) Vaginal Cleanse - Vaginal Dysbiosis
Phase 2RecruitingFreya Biosciences ApS302026-07-222026-10-15
A Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception
Levonorgestrel butanoate - Healthy Women, Female Contraception
Phase 2Not yet recruitingPremier Research1652026-04-012025-10-29
An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
SPT-300 - Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
Phase 2Enrolling by invitationSeaport Therapeutics3602025-09-022026-11-10
Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder
BXCL501 Sublingual Film - Bipolar I Disorder, Bipolar II Disorder
Phase 2CompletedBioXcel Therapeutics Inc332025-06-192026-10-05
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
SPT-300, Placebo - Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
Phase 2RecruitingSeaport Therapeutics3602025-06-192026-11-10
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
INT230-6, Eribulin, Trabectedin - Sarcoma,Soft Tissue
Phase 3RecruitingIntensity Therapeutics, Inc.3332024-06-282026-08-11
Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients
Amisulpride Injection, Dexamethasone - Nausea and Vomiting, Postoperative
Phase 2 / Phase 3CompletedAcacia Pharma Ltd4532024-01-182025-06-25
HEM1036 Phase 2 Study in Low Anterior Resection Syndrome
Lactobacillus Fermentum, Placebo - LARS - Low Anterior Resection Syndrome
Phase 2UnknownHEM Pharma Inc.672024-01-012023-05-25
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
RLS-0071, Placebo - Hypoxic-Ischemic Encephalopathy
Phase 2 / Phase 3RecruitingReAlta Life Sciences, Inc.1732023-07-272026-11-05
Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)
Tiratricol, Placebo - Monocarboxylate Transporter 8 Deficiency, Allan-Herndon-Dudley Syndrome
Phase 3CompletedRare Thyroid Therapeutics International AB202023-07-212026-04-08
A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH) - Attention Deficit/Hyperactivity Disorder
Phase 4CompletedCorium, Inc.1232023-06-022026-05-08
The Purpose of This Study is to Assess Clinical Efficacy and Safety of Berovenal® Intended to Promote Treatment and to Expedite Chronic Diabetic Foot Ulcer Healing
Berovenal®, NU-GEL Hydrogel with Alginate - Diabetic Foot Ulcer
Not applicableUnknownVULM s.r.o.662023-05-172024-09-05
An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), placebo - Attention Deficit/Hyperactivity Disorder
Phase 4CompletedCorium, Inc.2462023-03-222025-05-13
The Effectiveness of Sustained Heat Treatment on Delayed-Onset Muscle Soreness (DOMS)
ThermaCare HeatWraps - Delayed-Onset Muscle Soreness (DOMS)
Not applicableCompletedAziende Chimiche Riunite Angelini Francesco S.p.A1022023-01-302024-04-04
A Trial to Determine the Efficacy and Safety of Presendin in IIH
Presendin, Placebo - Idiopathic Intracranial Hypertension
Phase 3TerminatedInvex Therapeutics Ltd.142022-11-182024-04-24
Ibuprofen Liquid Capsules 2 x 200 mg Efficacy and PK/PD Study in Surgical Removal of Impacted Third Molars
Ibuprofen 200Mg Oral Cap, Ibuprofen 200Mg Oral Tablet, Placebo Liquid Capsule - Tooth, Impacted, Tooth Diseases
Phase 3CompletedReckitt Benckiser Healthcare (UK) Limited2942022-08-092023-06-22
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Bonjesta, Placebo - Morning Sickness
Phase 3SuspendedDuchesnay Inc.2742022-05-012026-04-03
Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens
TNX-2110, TNX-2120, TNX-2130 - Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2
Phase 1TerminatedTonix Pharmaceuticals, Inc.92022-01-072024-11-06
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
Simufilam, Placebo - Alzheimer Disease
Phase 3TerminatedCassava Sciences, Inc.11252021-11-182025-09-22
Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease
Simufilam, Placebo - Alzheimer Disease
Phase 3CompletedCassava Sciences, Inc.8042021-11-032025-05-25

Showing 20 of 92. Sign in to see all of them.

Conditions studied

Pain, Postoperative (12)  ·  Attention Deficit Disorder with Hyperactivity (4)  ·  Diabetic Foot (4)  ·  Diabetes Mellitus (3)  ·  Hernia, Inguinal (3)  ·  Nausea (3)  ·  Pain (3)  ·  Stress Disorders, Post-Traumatic (3)  ·  Vomiting (3)  ·  Acute Pain (2)  ·  Alzheimer Disease (2)  ·  Anxiety Disorders (2)  ·  Colorectal Neoplasms (2)  ·  Depression (2)  ·  Depressive Disorder (2)

Interventions

remimazolam (5)  ·  Bupivacaine (4)  ·  Midazolam (4)  ·  Ibuprofen (3)  ·  ST 1435 (3)  ·  Sodium Chloride (3)  ·  levonorgestrel butanoate (3)  ·  BufferGel (2)  ·  Dexmethylphenidate Hydrochloride (2)  ·  Levofloxacin (2)  ·  Nonoxynol (2)  ·  Simufilam (2)  ·  Tablets (2)  ·  dicyclomine, doxylamine, pyridoxine drug combination (2)  ·  ulipristal acetate (2)

Countries

United States (81)  ·  Germany (9)  ·  United Kingdom (8)  ·  France (7)  ·  Spain (7)  ·  Canada (6)  ·  Australia (4)  ·  Italy (4)  ·  Netherlands (4)  ·  Poland (4)  ·  Belgium (3)  ·  Hungary (3)  ·  Slovakia (3)  ·  Bulgaria (2)  ·  Czechia (2)

Top investigators

David Prior (11)  ·  Ann Childress, MD (3)  ·  Christina Wang, MD (2)  ·  David Walling, Ph.D. (2)  ·  Diana Blithe (2)  ·  Diana Blithe, PhD (2)  ·  James Kupiec, MD (2)  ·  Todd Bertoch, MD (2)  ·  Alison Edelman, MD (1)  ·  Andrew J. Bauer, MD (1)  ·  Andrew J. Cutler, MD (1)  ·  Anita L Nelson, MD (1)  ·  Atul R Mahableshwarkar, MD, DFAPA (1)  ·  BioXcel MM (1)  ·  Carolyn R Sikes, PhD (1)

Results publications

PMID 22792007, PMID 41500915, PMID 17766603, PMID 20716738, PMID 20825316, PMID 20843504, PMID 21099590, PMID 22659765, PMID 22972538, PMID 23152696, PMID 23390367, PMID 25052410, PMID 25502841, PMID 25884778, PMID 26267119, PMID 26363333, PMID 26844757, PMID 26874076, PMID 27881103, PMID 29342163, PMID 29723512, PMID 30252057, PMID 30292760, PMID 30849305, PMID 31231065, PMID 31381878, PMID 31398307, PMID 31976519, PMID 32168217, PMID 33587394, PMID 33908182, PMID 33970869, PMID 35857716, PMID 35865736, PMID 36347310, PMID 38295968, PMID 38350291, PMID 38477985, PMID 38477993, PMID 39316284, PMID 40314885, PMID 40693846

NIH funding

2025 (2), 2009 (1), 2015 (1), 2016 (1)